716 related articles for article (PubMed ID: 8778798)
1. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.
Snedeker SM; Diaugustine RP
Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798
[TBL] [Abstract][Full Text] [Related]
2. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
3. Potential benefits of estrogens and progestogens on breast cancer.
Schneider HP; Jackisch C
Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
[TBL] [Abstract][Full Text] [Related]
4. [Cancer risk under hormone therapy].
Lauritzen C
Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
[TBL] [Abstract][Full Text] [Related]
5. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer epidemiology.
Kelsey JL; Berkowitz GS
Cancer Res; 1988 Oct; 48(20):5615-23. PubMed ID: 3048646
[TBL] [Abstract][Full Text] [Related]
7. The pill and the breast.
Drife JO
IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
[TBL] [Abstract][Full Text] [Related]
8. Prolactin and breast carcinoma.
Smithline F; Sherman L; Kolodny D
N Engl J Med; 1975 Apr; 292(15):784-92. PubMed ID: 1089886
[TBL] [Abstract][Full Text] [Related]
9. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
Vessey MP
Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
12. [The present state of research on the relationship of oral contraceptives to breast cancer].
Pike MC
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
[TBL] [Abstract][Full Text] [Related]
13. Effects of sex steroids on proliferation in normal mammary tissue.
Söderqvist G
Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
15. Hormones and breast cancer.
ESHRE Capri Workshop Group
Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054
[TBL] [Abstract][Full Text] [Related]
16. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
17. Endogenous and exogenous endocrine factors.
Henderson BE
Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490
[TBL] [Abstract][Full Text] [Related]
18. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
19. Cellular basis of breast cancer susceptibility.
Russo J; Russo IH
Oncol Res; 1999; 11(4):169-78. PubMed ID: 10566615
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]